Monthly CME Meeting
Monthly CME Meeting on 29-09-2023 about SPINRAZATM, the first and only ASO (antisense oligonucleotide) treatment indicated for SMA (Spinal Muscular Atrophy) in pediatric and adult patients.
Login
Dont have Oman Neurology Society account? Sign up Forgot password?